Okupe Oluyemi's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Nov 14, 2024
- Accession no.
- 0001773751-24-000357
- Filed
- Nov 14, 2024
- Trade date
- Nov 13, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.28M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Okupe OluyemiCIK 0001907056 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +26,100 | $11.53 | +$300,933 | 171,863 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +83,209 | $5.01 | +$416,877.09 | 255,072 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −997 | $28.76F2 | −$28,673.72 | 254,075 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −1,391 | $28.72F3 | −$39,949.52 | 252,684 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −9,193 | $28.38F4 | −$260,897.34 | 243,491 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −131,305 | $30.06F5 | −$3,947,028.3 | 112,186 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 | Class A Common Stock | MOption exerciseDisposed | −26,100 | $0.00 | $0 | 65,732 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseDisposed | −83,209 | $0.00 | $0 | 536,824 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.74 - $28.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.16 - $28.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.10 - $28.83. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.